Thrombosis following desmopressin for uremic bleeding
- 1 May 1988
- journal article
- research article
- Published by Wiley in American Journal of Hematology
- Vol. 28 (1) , 63-65
- https://doi.org/10.1002/ajh.2830280115
Abstract
An elderly patient with evidence of atherosclerosis and uremic bleeding diathesis developed two foci of cerebral thrombosis immediately after an infusion of desmopressin (DDAVP). Because large molecular weight multimers of von Willebrand factor (vWF) have been demonstrated to cause platelet aggregation under conditions of elevated fluid shear stress as occurs in atherosclerotic vessels, we investigated his plasma vWF at the time of the event and compared it to baseline values obtained 2 weeks later. Unusually large vWF multimers induced by the DDAVP infusion were present and likely contributed to the thrombotic process. Consequently, we believe DDAVP should be given with greater caution to patients with atherosclerosis.Keywords
This publication has 8 references indexed in Scilit:
- Involvement of von willebrand factor in thrombosis following asparaginase‐prednisone‐vincristine therapy for leukemiaAmerican Journal of Hematology, 1987
- Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation.Journal of Clinical Investigation, 1986
- Factor VIII Concentrate-Responsive Thrombocytopenia, Hemolytic Anemia, and Nephropathy Evidence that Factor VIIIJournal of Pediatric Hematology/Oncology, 1986
- Elevated Plasma von Willebrand Factor Levels and Arterial Occlusive Complications Associated with Cisplatin-Based ChemotherapyOncology, 1985
- Platelet Aggregation Induced by I-Desamino-8-D-Arginine Vasopressin (dDAVP) in Type IIb von Willebrand's DiseaseNew England Journal of Medicine, 1983
- Unusually Large Plasma Factor VIII: von Willebrand Factor Multimers in Chronic Relapsing Thrombotic Thrombocytopenic PurpuraNew England Journal of Medicine, 1982
- Multimeric composition of factor VIII/von Willebrand factor following administration of DDAVP: implications for pathophysiology and therapy of von Willebrand's disease subtypesBlood, 1982
- Increased factor VIII/von Willebrand factor antigen and von Willebrand factor activity in renal failureThe American Journal of Medicine, 1979